Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in NXTC held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLC | 288K | $461K | +21.0% | 7.982% | 0.05% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 277K | $444K | β | 7.674% | 0.00% |
| 3 | Sofinnova Investments, Inc. | 223K | $356K | 0.0% | 6.164% | 0.02% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 171K | $274K | +182.8% | 4.740% | 0.00% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 157K | $251K | -2.3% | 4.342% | 0.00% |
| 6 | MILLENNIUM MANAGEMENT LLC | 88K | $141K | β | 2.439% | 0.00% |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 85K | $135K | +21.6% | 2.345% | 0.00% |
| 8 | Squadron Capital Management LLC | 64K | $103K | -75.7% | 1.785% | 0.03% |
| 9 | Verdad Advisers, LP | 60K | $97K | +40.7% | 1.674% | 0.09% |
| 10 | PFIZER INC | 44K | $73K | -71.1% | 1.228% | 0.04% |
| 11 | Affinity Asset Advisors, LLC | 42K | $67K | -82.7% | 1.162% | 0.00% |
| 12 | BlackRock, Inc. | 37K | $60K | +34.4% | 1.034% | 0.00% |
| 13 | JANE STREET GROUP, LLC | 33K | $52K | β | 0.906% | 0.00% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 30K | $48K | -3.8% | 0.828% | 0.00% |
| 15 | CARDIFF PARK ADVISORS, LLC | 22K | $35K | 0.0% | 0.604% | 0.00% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 16K | $26K | +0.7% | 0.447% | 0.00% |
| 17 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 13K | $20K | β | 0.346% | 0.00% |
| 18 | DIADEMA PARTNERS LP | 8K | $12K | β | 0.214% | 0.00% |
| 19 | BARCLAYS PLC | 6K | $9K | +1.8% | 0.159% | 0.00% |
| 20 | Persistent Asset Partners Ltd | 2K | $3K | β | 0.055% | 0.00% |
| 21 | Tower Research Capital LLC (TRC) | 2K | $3K | β | 0.048% | 0.00% |
| 22 | UBS Group AG | 594 | $951 | +75.7% | 0.016% | 0.00% |
| 23 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 83 | $133 | β | 0.002% | 0.00% |
| 24 | JPMORGAN CHASE & CO | 61 | $107 | 0.0% | 0.002% | 0.00% |
| 25 | MORGAN STANLEY | 66 | $106 | 0.0% | 0.002% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in NXTC β a direct measure of their conviction.
Filings activity in NXTC during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new NXTC position in Q2 2026
Institutions that fully closed their NXTC position in Q2 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 30 | +15% | 48.04% | 19.70 pp | $3M | 88% |
| Q1 2026 | 26 | +8.3% | 67.74% | +6.76 pp | $23M | 14% |
| Q4 2025 | 24 | +41% | 60.98% | +24.86 pp | $27M | +451% |
| Q3 2025 | 17 | 47% | 36.12% | 10.97 pp | $5M | 11% |
| Q2 2025 | 32 | 16% | 47.09% | 12.15 pp | $5M | 24% |
| Q1 2025 | 38 | 19% | 59.24% | 6.96 pp | $7M | 44% |
| Q4 2024 | 47 | +6.8% | 66.20% | +4.59 pp | $13M | 39% |
| Q3 2024 | 44 | β | 61.61% | β | $21M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.
Quick answers to the most common questions about buying NXTC stock.
Based on Q2 2026 13F filings, institutional ownership of NextCure, Inc. stands at 48.0%, held across 30 reporting institutions.
Ikarian Capital, LLC is the largest reported institutional holder of NXTC, with approximately 288,303 shares worth $0.00B as of Q2 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of NXTC, including RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC.
Our composite Smart Money Score for NXTC is 54 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
10 institutions opened new positions in NXTC during Q2 2026, while 7 fully exited. 0 added to existing positions and 19 trimmed.
NXTC institutional ownership fell by 19.70 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 87.4% of all reported 13F value in NXTC, and the top 25 account for 100.0%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.